Skip to content
Open access

HSP90AA1 induces M2 macrophage polarization via stabilizing ITGB1 and promoting CCL2 secretion in nasopharyngeal carcinoma

Oct 2026 · Scientific Reports · 0 citations

TL;DR

In vitro models and retrospective clinical correlation suggest that the HSP90AA1-ITGB1-CCL2 axis may drive immunosuppressive TME remodeling in NPC, highlighting HSP90AA1 as a promising predictive biomarker and therapeutic target against immunotherapy resistance.

Abstract

Nasopharyngeal carcinoma (NPC) presents a major treatment challenge, largely due to immunotherapy resistance. The molecular mechanisms that drive the remodeling of the immunosuppressive tumor microenvironment (TME) in NPC are still not well understood. This study explored how heat shock protein 90 alpha family class A member 1 (HSP90AA1) regulated the NPC immune microenvironment. A total of 54 NPC patients receiving first-line immunotherapy were analyzed by immunohistochemistry (IHC). High HSP90AA1 expression predicted shorter progression-free survival (PFS). According to the TIMER database, HSP90AA1 expression positively correlated with M2 macrophage infiltration. Additionally, we established an indirect co-culture model containing NPC cells and THP-1-derived macrophages and found that HSP90AA1 facilitated macrophage M2 polarization. According to the results of co-immunoprecipitation (Co-IP) and cycloheximide (CHX) chase assays, HSP90AA1 associated with integrin β1 (ITGB1) and stabilized its protein expression, subsequently increasing C-C motif chemokine ligand 2 (CCL2) secretion. HSP90AA1 knockdown suppressed CCL2 secretion and M2 polarization, and ITGB1 overexpression partially reversed this effect. Taken together, our in vitro models and retrospective clinical correlation suggest that the HSP90AA1-ITGB1-CCL2 axis may drive immunosuppressive TME remodeling in NPC, highlighting HSP90AA1 as a promising predictive biomarker and therapeutic target against immunotherapy resistance.

Read PDF

Similar papers

Open access Aug 2026

FSTL1 promotes M2 polarization of macrophages via the DIP2A–Smad2/3 Axis in gastric cancer

It is indicated that FSTL1 represents a promising immunomodulatory target and highlight its potential as a therapeutic target to reprogram the immunosuppressive microenvironment and improve the efficacy of GC immunotherapy.

Ming Yang, Rong-Fei Wang, Xiao Wang et al. · 0 citations
Open access Sep 2026

NCAPD3 induces M2 polarization of peripheral macrophages in lung adenocarcinoma by promoting the binding of E2F1 to the FOXM1 promoter region.

Serving as a highly prevalent malignant tumor, lung adenocarcinoma (LUAD) is frequently associated with the establishment of an immunosuppressive tumor microenvironment during its initiation and progression, where M2-polarized macrophages exert pivotal effects. NCAPD3 acts as an oncogenic driver in multiple tumors; how...

Wei-Xi Zhang, Kong-Jun Zou · 0 citations
Open access Sep 2026

The effect and mechanism of TIPE in promoting M2 polarization through DcR3 in the microenvironment of colorectal cancer

Elevated expression of tumor necrosis factor α-induced protein 8 (TIPE) is observed in colorectal cancer (CRC) and is known to regulate decoy receptor 3 (DcR3) expression while promoting M2 polarization of macrophages. However, the precise role of DcR3 in macrophage M2 polarization remains to be elucidated. We employed...

Shi-Ying Zhang, Chun-Lin Shen, Ze-Yang Lin et al. · 0 citations
Open access Sep 2026

TPPP3 Overexpression Suppresses Nasopharyngeal Carcinoma Progression and Promotes Immune Microenvironment Remodeling Through HSPA8 Association

Simple Summary Nasopharyngeal carcinoma is a head and neck cancer linked to Epstein–Barr virus infection. Some patients respond well to immunotherapy, but many do not, and the reasons for this difference remain unclear. In this study, we investigated a protein called TPPP3, which is present at low levels in nasopharyng...

Sheng-Wei Li, Jie-Jun Liao, Jia-Wei Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.